Xiangxiang Ma, Partner at Anjie Broad LLP, analyzes a newly-released standard which forms a key part of China’s framework regulating clinical trials
July 27, 2026
Features & Analyses
AI is now all-pervasive and raises many novel legal issues. Wu Qiong and Wang Xuying of Haiwen & Partners explore a significant Intermediate People’s Court ruling on employee dismissal ostensibly driven by a the adoption of AI technology
July 17, 2026Jianwei (Jerry) Fang, Cathy (Yian) Chen and Ke Dong of Zhong Lun Law Firm analyse China’s newly promulgated State Council Regulation on Outbound Investment. This article unpacks how the Regulation reinforces and expands the pre-existing outbound direct investment governance framework, broadens the regulatory perimeter governing cross-border outbound investment activities, and outlines critical compliance ramifications for Chinese enterprises undertaking overseas investment transactions
July 06, 2026Jun Luo, a Ph.D. Candidate in Intellectual Property Law at Tongji University Law School, examines a key Supreme People’s Court case from a data law perspective, analyzing its implications for data rights, platform responsibilities, user autonomy, and the evolving interface between data regulation and competition law in China
June 26, 2026Casper Sek of Jingtian & Gongcheng examines the development of China’s personal information protection compliance audit framework, in light of new and imminent further changes in this important area
June 15, 2026Jianwei (Jerry) Fang and Rui Yang of Zhong Lun Law Firm analyze the implications of China’s new rules targeting the illegal operation of securities business in the Mainland by offshore institutions and their onshore affiliates, intermediaries and internet platforms, and offer practical guidance for foreign financial institutions to cope with recent enforcement trends
June 02, 2026Jianwei (Jerry) Fang, Peng Zhang, Haoyi Sun, Jiaying (Kate) Jiang and Chen (Cissy) Chen of Zhong Lun Law Firm examine and analyze China’s Regulations on Countering Unlawful Extraterritorial Jurisdiction, outlining the legislative purpose, broader policy context, and key provisions, and offering practical guidance for companies engaged in cross-border operations
May 08, 2026In 2025, there was continuity and change in U.S. policy that impacted both Chinese and APAC investment into the U.S., and U.S. investment into China. For the investment community, a key question has become how to navigate the U.S. regulatory environment while maximizing business opportunities in the two jurisdictions. A U.S. corporate and regulatory lawyer at a U.S. firm helps make sense of the developments
April 02, 2026Jianwei (Jerry) Fang, Haoyi Sun, Junda He and Yi Dai of Zhong Lun Law Firm examine and discuss the key types, trends, and observations in U.S. litigation involving Chinese enterprises in 2025
March 31, 2026Xiangxiang Ma of Anjie Broad Law Firm explores the key legal and regulatory developments affecting China’s vital healthcare sector in 2025
March 31, 2026
